Enliven Therapeutics, Inc. (ELVN)
Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates. The company was founded by Sam S. Kintz, Joe P. Lyssikatos, and Anish Patel in June 2019 and is headquartered in Boulder, CO.
Address
6200 LOOKOUT ROAD
BOULDER, CO 80301
Founded
2019
Number of Employees
46
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)